Chemokines in cancer - PubMed (original) (raw)
Review
Chemokines in cancer
Alain P Vicari et al. Cytokine Growth Factor Rev. 2002 Apr.
Abstract
Chemokines participate, by regulating cell trafficking and controlling angiogenesis, in the host response during infection and inflammation. Most of these mechanisms are also operating in cancer. The stimulation of angiogenesis and tumor growth--directly or indirectly through the recruitment of tumor-associated macrophages--are typical situations where chemokines promote tumor development. On the other hand, chemokines could be used to the benefit of cancer patients as they act in the recruitment of dendritic cells (DC) or/and effector cells or for their angiostatic properties. However, chemokine-mediated recruitment of immature DC within tumors, due to factors produced by the tumor milieu, could lead to the induction of immune tolerance and, therefore, novel strategies to eradicate tumors based on chemokines should attempt to avoid this risk.
Similar articles
- The chemokine system in cancer biology and therapy.
Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R. Mantovani A, et al. Cytokine Growth Factor Rev. 2010 Feb;21(1):27-39. doi: 10.1016/j.cytogfr.2009.11.007. Epub 2009 Dec 8. Cytokine Growth Factor Rev. 2010. PMID: 20004131 Review. - Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms.
Vicari AP, Ait-Yahia S, Chemin K, Mueller A, Zlotnik A, Caux C. Vicari AP, et al. J Immunol. 2000 Aug 15;165(4):1992-2000. doi: 10.4049/jimmunol.165.4.1992. J Immunol. 2000. PMID: 10925282 - Chemokines in cancer.
Chow MT, Luster AD. Chow MT, et al. Cancer Immunol Res. 2014 Dec;2(12):1125-31. doi: 10.1158/2326-6066.CIR-14-0160. Cancer Immunol Res. 2014. PMID: 25480554 Free PMC article. Review. - The countercurrent principle in invasion and metastasis of cancer cells. Recent insights on the roles of chemokines.
Opdenakker G, Van Damme J. Opdenakker G, et al. Int J Dev Biol. 2004;48(5-6):519-27. doi: 10.1387/ijdb.041796go. Int J Dev Biol. 2004. PMID: 15349826 Review. - Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.
Marcuzzi E, Angioni R, Molon B, Calì B. Marcuzzi E, et al. Int J Mol Sci. 2018 Dec 27;20(1):96. doi: 10.3390/ijms20010096. Int J Mol Sci. 2018. PMID: 30591657 Free PMC article. Review.
Cited by
- Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma.
Liu Z, Sun DX, Teng XY, Xu WX, Meng XP, Wang BS. Liu Z, et al. Endocr Pathol. 2012 Dec;23(4):247-53. doi: 10.1007/s12022-012-9223-x. Endocr Pathol. 2012. PMID: 23070788 - The Serum Levels of the Soluble Factors sCD40L and CXCL1 Are Not Indicative of Endometriosis.
Pateisky P, Pils D, Kuessel L, Szabo L, Walch K, Obwegeser R, Wenzl R, Yotova I. Pateisky P, et al. Biomed Res Int. 2016;2016:2857161. doi: 10.1155/2016/2857161. Epub 2016 Apr 17. Biomed Res Int. 2016. PMID: 27190986 Free PMC article. - Tumor immune escape mechanisms: impact of the neuroendocrine system.
Lang K, Entschladen F, Weidt C, Zaenker KS. Lang K, et al. Cancer Immunol Immunother. 2006 Jul;55(7):749-60. doi: 10.1007/s00262-006-0126-x. Epub 2006 Jan 25. Cancer Immunol Immunother. 2006. PMID: 16435128 Free PMC article. Review. - Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy.
Yang K, Zhao Y, Sun G, Zhang X, Cao J, Shao M, Liang X, Wang L. Yang K, et al. Front Immunol. 2023 Jan 19;13:1081546. doi: 10.3389/fimmu.2022.1081546. eCollection 2022. Front Immunol. 2023. PMID: 36741400 Free PMC article. Review. - Nox1 expression determines cellular reactive oxygen and modulates c-fos-induced growth factor, interleukin-8, and Cav-1.
Arnold RS, He J, Remo A, Ritsick D, Yin-Goen Q, Lambeth JD, Datta MW, Young AN, Petros JA. Arnold RS, et al. Am J Pathol. 2007 Dec;171(6):2021-32. doi: 10.2353/ajpath.2007.061144. Epub 2007 Nov 30. Am J Pathol. 2007. PMID: 18055552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources